Facebook
Twitter
LinkedIn
Forward
Title |
Program description | Type | Credit | Event date | |
|---|---|---|---|---|---|
| Pharmacy Podcast Episode 142 : What’s the Best for CRS? |
Available until September 1, 2024 - Podcast Online CME Education Jonathan Leung, PharmD, BCPS, BCPP provides updates on the clozapine REMS program, reviews the therapeutic benefits of clozapine, as well as key adverse events. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 141 : Pitter Patter, Let’s Get ATTR: Medications for Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) |
Available until September 1, 2024 - Podcast Online CME Education Kelli Herrin, PharmD reviews the pathophysiology of transthyretin amyloidosis cardiomyopathy and provides updates on medication options. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 140 : Updates on the Clozapine REMS Program: An Important Relic or Fool’s Gold of Safety? |
Available until September 1, 2024 - Podcast Online CME Education Jonathan Leung, PharmD, BCPS, BCPP provides updates on the clozapine REMS program, reviews the therapeutic benefits of clozapine, as well as key adverse events. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 139 : On Another Level: The Role of Therapeutic Drug Monitoring in Inflammatory Bowel Disease |
Available until September 1, 2024 - Podcast Online CME Education Sarah A. Chase, PharmD reviews the pathophysiology and current treatment strategies for inflammatory bowel disease, defines the clinical application of therapeutic drug monitoring of biologic therapies used in inflammatory bowel disease and discusses biologic therapy optimization based on therapeutic drug monitoring. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 138 : All-In on Insulin? Use of High-Dose Insulin Euglycemic Therapy in Calcium Channel Blocker Overdose |
Available until September 1, 2024 - Podcast Online CME Education Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 137 : Measuring Value in Drug Therapy |
Available until September 1, 2024 - Podcast Online CME Education Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 136 : Verification Decision Support: May AI Take Your Order? |
Available until September 1, 2024 - Podcast Online CME Education Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 135 : A Hard-Pressed Debate: The Role of Terlipressin in Hepatorenal Syndrome |
Available until September 1, 2024 - Podcast Online CME Education Nikitha Yagnala, PharmD and Andy J. Jatis, PharmD, BCPS describe the pathophysiology of hepatorenal syndrome (HRS), describe the pathophysiology of hepatorenal syndrome (HRS) and outline an optimal patient care plan for the management of HRS. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 134 : Freezing Ethylene Glycol Toxicity |
Available until September 1, 2024 - Podcast Online CME Education Kamryn R. Storm, PharmD outlines the mechanism of toxicity for ethylene glycol, identifies clinical findings of ethylene glycol toxicity and selects treatment regimens for suspected ethylene glycol toxicity. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 133 : Emerging Antibiotics – Tetra(cycle)ine Back to Basics |
Available until September 1, 2024 - Podcast Online CME Education Ashton C. Praska, PharmD describes tetracycline resistance mechanisms utilized by bacteria, identifies how Omadacycline/Eravacycline can overcome common tetracycline resistance mechanisms and identifies clinical scenarios where Omadacycline/Eravacycline could be considered for use. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 132 : Pharmacotherapy for the Treatment of Obesity |
Available until September 1, 2024 - Podcast Online CME Education Kristina M. Thurber, PharmD, BCPS recognizes pharmacotherapy for the treatment of obesity and explain mechanisms of action for each class, discusses and compares clinical data and weight loss outcomes for common treatment options, and determines an optimal pharmacologic regimen for the treatment of obesity given patient-specific factors. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 131 : Off the Chain: The Drug Supply Chain and Medication Shortages |
Available until September 1, 2024 - Podcast Online CME Education Jo Ann Leal, PharmD describes the key components of the drug supply chain and the impact of drug shortages, identifies common organizational strategies used to mitigate drug shortages and evaluates recent national efforts to stabilize the drug supply chain. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 130 : Clostridioides difficile Infection: Do We C the Diff-erence in Preventing Recurrence? |
Available until September 1, 2024 - Podcast Online CME Education Andrew (Andy) F. Wiener, PharmD describes the pathogenesis and risk factors of C. diff infection and recurrence, reviews the preferred treatment modalities for prevention of C. diff recurrence and describes the cost-benefit analysis supporting guideline-directed management of C. diff infections. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 129: Pharmacologic Treatment of Drug Resistant Hypercholesterolemia |
Available until September 1, 2024 - Podcast Online CME Education Seth M. Kriha, PharmD identifies guideline recommended treatment to reduce LDL-C, evaluates landmark clinical trials for novel therapeutic agents indicated for treatment resistant hypercholesterolemia and develops a pharmacologic care plan for a patient with treatment resistant hypercholesterolemia. |
Enduring |
|
Ongoing | |
| Pharmacy Podcast Episode 128: It’s Going Tibia Okay: Supportive Bone Health in Oncology |
|
Enduring |
|
Ongoing |